Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Active RB elicits late G1/S inhibition.

Angus SP, Fribourg AF, Markey MP, Williams SL, Horn HF, DeGregori J, Kowalik TF, Fukasawa K, Knudsen ES.

Exp Cell Res. 2002 Jun 10;276(2):201-13.

PMID:
12027450
2.

Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Sever-Chroneos Z, Angus SP, Fribourg AF, Wan H, Todorov I, Knudsen KE, Knudsen ES.

Mol Cell Biol. 2001 Jun;21(12):4032-45.

3.

RB-dependent S-phase response to DNA damage.

Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JY, Knudsen ES.

Mol Cell Biol. 2000 Oct;20(20):7751-63.

4.

Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.

Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES.

Cell Growth Differ. 2000 Jul;11(7):361-72.

5.

BRG-1 is required for RB-mediated cell cycle arrest.

Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7748-53.

6.

Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.

Strobeck MW, Fribourg AF, Puga A, Knudsen ES.

Oncogene. 2000 Apr 6;19(15):1857-67.

7.

Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.

Knudsen KE, Fribourg AF, Strobeck MW, Blanchard JM, Knudsen ES.

J Biol Chem. 1999 Sep 24;274(39):27632-41.

Supplemental Content

Loading ...
Support Center